Advanced Biomed Inc.
$5
▲
2.02%
2026-04-21 05:06:00
www.advanbiomed.com
NCM: ADVB
Explore Advanced Biomed Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.55 M
Current Price
$5
52W High / Low
$48.8 / $3.61
Stock P/E
1.49
Book Value
$8.76
Dividend Yield
—
ROCE
—
ROE
80.18%
Face Value
—
EPS
$3.52
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
31
Beta
—
Debt / Equity
7.54
Current Ratio
8.56
Quick Ratio
—
Forward P/E
—
Price / Sales
—
Enterprise Value
$5.25 M
EV / EBITDA
-1.77
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | iSpecimen Inc. | $0.13 | — | $4.05 M | — | -355.55% | -3.28% | $3.18 / $0.1 | $0.31 |
| 2. | Illumina, Inc. | $131.09 | 24.09 | $19.95 B | — | 16.15% | 33.36% | $155.53 / $69.83 | $17.8 |
| 3. | Medpace Holdings, Inc. | $513.23 | 33.75 | $14.67 B | — | 84.68% | 70.23% | $628.92 / $250.05 | $16.18 |
| 4. | Quest Diagnostics Incorporated | $200.41 | 22.15 | $22.16 B | 1.76% | 11.16% | 14.75% | $213.5 / $160.02 | $65.18 |
| 5. | FONAR Corporation | $18.8 | 15.61 | $117.93 M | — | 5.81% | 6.01% | $18.86 / $12 | $27.01 |
| 6. | Thermo Fisher Scientific Inc. | $521.21 | 29.42 | $194.29 B | 0.36% | 8.52% | 13.02% | $643.99 / $385.46 | $141.96 |
| 7. | Revvity, Inc. | $93.89 | 28.42 | $10.54 B | 0.3% | 3.29% | 3.22% | $118.3 / $81.36 | $64.57 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -0.4 M | -0.52 M | -0.76 M | -0.28 M | -0.52 M |
| Net Profit | 6.86 M | -0.39 M | -1.38 M | -0.91 M | -0.27 M |
| EPS in Rs | 5.03 | -0.28 | -1.01 | -0.67 | -0.19 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | — | 0 M | 0 M | 0 M |
| Operating Profit | — | -2.54 M | -3.07 M | -2.37 M |
| Net Profit | — | -2.78 M | -3.73 M | -4.03 M |
| EPS in Rs | -3.2 | -2.04 | -2.74 | -2.95 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | — | 4.46 M | 4.6 M | 6.71 M |
| Total Liabilities | — | 2.8 M | 3.29 M | 3.22 M |
| Equity | — | 1.66 M | 1.31 M | 3.49 M |
| Current Assets | — | 3.05 M | 2.79 M | 5.01 M |
| Current Liabilities | — | 2.73 M | 3.28 M | 2.99 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -2.13 M | -2.96 M | -0.74 M | -0.47 M |
| Investing CF | -0.07 M | -0.26 M | -1.08 M | -0.03 M |
| Financing CF | 1.87 M | 0.46 M | 6.1 M | 0.7 M |
| Free CF | -2.2 M | -3.18 M | -2.05 M | -0.5 M |
| Capex | -0.07 M | -0.21 M | -1.31 M | -0.03 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 25.46% | 7.32% | -119.24% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-20 | 1:0.05 |